Giridhar Maddirevula

Giridhar Maddirevula, MD, MBA, FIPS, currently serves as Medical Director of Clinical Development at Intra-Cellular Therapies since December 2022, having previously held the position of Associate Medical Director in the same role. From June 2014 to October 2022, Giridhar was a Consultant Psychiatrist at Lalitha Neuropsychiatry Center, where responsibilities included patient evaluations and treatment plan development. Additional experience includes serving as Lead Medical Reviewer at Novartis and as a Drug Safety Physician at Global Allied Pharmaceuticals, focusing on the analysis of safety data and compliance with regulatory requirements. Giridhar's earlier career at Bristol Myers Squibb as a Medical Review Safety Physician established a strong foundation in safety assessments for clinical and post-market data. Educational qualifications include an MD in Psychiatry from NTR University of Health Sciences, obtained in 2014, and an MBBS from the same institution, completed in 2002.